SCHEMBL6979235

SCHEMBL6979235

O=C(C(=NO)c1cc(F)ccn1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
GAA P10253 3/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 3/20 0.39
CES1 P23141 5/20 0.39
CES2 O00748 4/20 0.39
KDM4E B2RXH2 2/20 0.37
KDM6B O15054 2/20 0.37
KDM4A O75164 2/20 0.37
KDM5C P41229 2/20 0.37
KDM4C Q9H3R0 2/20 0.37
KDM2A Q9Y2K7 2/20 0.37
KDM3A Q9Y4C1 2/20 0.37
TET3 O43151 1/20 0.37
BBOX1 O75936 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KDM5A P29375 1/20 0.37
ASPH Q12797 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2763123 0.80 KMT2A (0.58) NPC1RAB9AGAACYP2C19KMT2A
SCHEMBL2763124 0.80 KMT2A (0.58) NPC1RAB9AGAACYP2C19KMT2A
SCHEMBL2512214 0.76 CES2 (0.58) NPC1RAB9AGAACYP2C19KMT2A
SCHEMBL2475232 0.76 CES2 (0.58) NPC1RAB9AGAACYP2C19KMT2A
Methane SCHEMBL27516308 0.76 KMT2A (0.58) NPC1RAB9AKMT2ACES1CES2
SCHEMBL13741003 0.72 GPBAR1 (0.43) NPC1RAB9AGAACYP2C19KMT2A
SCHEMBL13740721 0.72 GPBAR1 (0.43) NPC1RAB9AGAACYP2C19KMT2A
SCHEMBL29954072 0.71 KDM4E (0.61) KDM4EKDM6BKDM4AKDM5CKDM4C
SCHEMBL231979 0.71 KDM4E (0.61) KDM4EKDM6BKDM4AKDM5CKDM4C
SCHEMBL4353902 0.71 GAA (0.65) NPC1RAB9AGAACYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169317-B1 TRIARYLIMIDAZOLES SMITHKLINE BEECHAM CORP (US) 2003-01-15 EP disclosed
US-6465493-B1 SUCH AS 4-(4-(4-FLUOROPHENYL)-5-(2-PYRIDYL)-1-HYDROXY-1H-IMIDAZOL-2-YL)BENZONITRILE; ALK5 MEDIATED DISEASES SUCH AS ARTHRITIS, OSTEOPOROSIS, KIDNEY AND RENAL DISEASES, CONGES-TIVE HEART FAILURE, ULCERS, DIABETIC NEPHROPATHY SMITHKLINE BEECHAM CORPORATION 2002-10-15 US disclosed
EP-1169317-A1 TRIARYLIMIDAZOLES SMITHKLINE BEECHAM CORPORATION (US) 2002-01-09 EP disclosed
WO-2000061576-A1 TRIARYLIMIDAZOLES SMITHKLINE BEECHAM CORPORATION (US) 2000-10-19 WO disclosed